Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - prilocaine hydrochloride, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - indications as at 12 march 1996: citanest solutions are indicated for the production of local or regional anaesthesia by infiltration techniques; intravenous regional anaesthesia; by peripheral nerve block techniques such as intercostal blocks; major plexus blocks such as brachial plexus blocks and by epidural and subarachnoid blocks.

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 0.0061 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 14 july 2003 : citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - prilocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; water for injections - citanest solutions are indicated for the production of local or regional anaesthesia by infiltration techniques; intravenous regional anesthesia; by peripheral nerve block techniques such as intercostal blocks; major plexus blocks such as brachial plexus blocks and by epidural and subarachnoid blocks.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - prilocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride - citanest solutions are indicated for the production of local or regional anaesthesia by infiltration techniques; intravenous regional anaesthesia; by peripheral nerve block techniques such as intercostal blocks; major plexus blocks such as brachial plexus blocks and by epidural and subarachnoid blocks.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - prilocaine hydrochloride 0.5%; prilocaine hydrochloride 5 mg/ml; prilocaine hydrochloride 0.5% - solution for injection - 0.5 % - active: prilocaine hydrochloride 0.5% excipient: sodium chloride sodium hydroxide water for injection active: prilocaine hydrochloride 5 mg/ml excipient: hydrochloric acid as 2m solution for ph adjustment (ph 5 - 7) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 5 - 7) water for injection active: prilocaine hydrochloride 0.5% excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - the production of local or regional anaesthesia by the following techniques: · local infiltration · minor and major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - prilocaine hydrochloride - solution for injection - 10mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - indications as at 23 july 2003 : citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; felypressin, quantity: 0.03 iu/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; acetic acid; sodium acetate; chlorobutanol hemihydrate; sodium hydroxide - citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

Ireland - English - HPRA (Health Products Regulatory Authority)

dentsply detrey gmbh - felypressin; prilocaine hydrochloride - solution for injection - 3 %w/v +0.54 microgram(s)/millilitre - amides; prilocaine, combinations

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; felypressin, quantity: 0.03 iu/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide; sodium acetate; chlorobutanol hemihydrate; acetic acid - indications as at 23 july 2003 : citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block tecniques.